In patients with severe COVID-19, but less so in patients with mild disease, lymphopenia is commonly observed, with drastically reduced numbers of B cells, helper (i.e. CD4+) T cells (THs), cytotoxic (i.e. CD8+) T cells (CTLs) and NK cells. The gene discussed is CD8A; the disease is COVID-19.